Increased Intraplatelet ADMA Level May Promote Platelet Activation in Diabetes Mellitus

BACKGROUND: Antiplatelet therapy has become a standard therapeutic approach in the secondary prevention of cardiovascular system disorders of thrombotic origin. Patients with concomitant diabetes mellitus (DM) obtain fewer benefits from this treatment. Hence, the pathophysiology of altered platelet...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oxid Med Cell Longev
Main Authors: Gawryś, Jakub, Wiśniewski, Jerzy, Szahidewicz-Krupska, Ewa, Gajecki, Damian, Leśniewska, Julia, Majda, Filip, Gawryś, Karolina, Fortuna, Paulina, Mlynarz, Piotr, Doroszko, Adrian
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7542534/
https://ncbi.nlm.nih.gov/pubmed/33062144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/6938629
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados